3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
12
Carcinoma, Hepatocellular
8
Small Cell Lung Carcinoma
7
Lung Neoplasms
7
Colorectal Neoplasms
7
Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Carcinoma, Renal Cell
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Breast Neoplasms
3
Small Cell Lung Cancer Extensive Stage
2
Sarcoma
2
Liver Neoplasms
2
Extensive Stage Lung Small Cell Carcinoma
2
Carcinoma, Transitional Cell
2
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unresectable Hepatocellular Carcinoma
1
Stomach Neoplasms
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Interventions
patritumab deruxtecan
1
durvalumab
1
Pemetrexed
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Non-Small Cell Lung Cancer Metastatic
×
atezolizumab
×
30 days
×
Clear all
No trials found.